Search

Background/objective: Data on IgG4-related disease (IgG4-RD) come almost exclusively from cohorts from Asia, Europe, and North America. We conducted this study to describe the clinical presentation, phenotype distribution, and association with sex, ethnicity, and serological markers in a large cohort of Latin American patients with IgG4-RD., Methods: We performed a multicenter medical records review study including 184 Latin American IgG4-RD patients. We assigned patients to clinical phenotypes: group 1 (pancreato-hepato-biliary), group 2 (retroperitoneal/aortic), group 3 (head and neck-limited), group 4 (Mikulicz/systemic), and group 5 (undefined). We focused the analysis on how sex, ethnicity, and clinical phenotype may influence the clinical and serological presentation., Results: The mean age was 50.8 ± 15 years. Men and women were equally affected (52.2% vs 48.8%). Fifty-four patients (29.3%) were assigned to group 1, 21 (11.4%) to group 2, 57 (30.9%) to group 3, 32 (17.4%) to group 4, and 20 (10.8%) to group 5. Male sex was associated with biliary tract (odds ratio [OR], 3.4; 95% confidence interval [CI], 1.36-8.26), kidney (OR, 3.4; 95% CI, 1.28-9.25), and retroperitoneal involvement (OR, 5.3; 95% CI, 1.45-20). Amerindian patients presented more frequently with atopy history and gallbladder involvement. Group 3 had a female predominance., Conclusions: Latin American patients with IgG4-RD were younger, and men and women were equally affected compared with White and Asian cohorts. They belonged more commonly to group 1 and group 3. Retroperitoneal and aortic involvement was infrequent. Clinical and serological features differed according to sex, ethnicity, and clinical phenotype., Competing Interests: The authors declare no conflict of interest., (Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.)

Collective efficacy, defined as a group's shared belief about its conjoint capability to organize and execute courses of action, plays a pivotal role in understanding the dynamics of sports teams, since it influences what individuals choose to do as team members, how much they invest in motivational terms to perform actions, how much they work collectively, and for how long they persist despite failure. Through a systematic review, it was investigated how collective efficacy has been assessed in the context of soccer and which indicators, attributes, and psychometric properties have been contemplated in the instruments used. Following the PRISMA guidelines, 22 articles were retrieved through electronic databases (APA PsycINFO; SPORTDiscus; Science Direct; BVS; Web of Science; Scopus; PubMed; and Scielo), using as descriptors, in English, Spanish, and Portuguese, collective efficacy and soccer, combined by the Boolean operators AND and OR. The study did not delimit the initial year of publication for the searches carried out, including all articles found until January 14, 2021 (date of the last update). The following eligibility criteria were adopted: scientific articles published in journals; original studies, which specified the instrument used to assess collective efficacy and carried out with soccer athletes. Five instruments (FCEQ, CEQS, CEI, CEC, and CEQsoccer) that evaluated technical-tactical and psychological attributes associated with collective efficacy in soccer players were identified. In most studies, psychometric properties were restricted to content validity and reliability (internal consistency), and there were no suitable validation processes for the instruments used to measure collective efficacy, which can be considered a limiting factor for understanding this psychological construct in soccer modality.

Background: The detection of anti-transglutaminase IgA (tTG) and anti-endomysial (EMA) is used for screening of celiac disease (CD) with a sensitivity and specificity of 90 and 99% respectively. There is an association between CD and connective tissue diseases (CTD)., Aim: To report the frequency of IgA tTG and EMA in patients with a definite diagnosis of CTD and inflammatory arthropathies (IA)., Material and Methods: One hundred forty nine patients, aged 19 to 86 years (133 females) with CTD and IA were studied. tTG were determined by ELISA and EMA by indirect immunofluorescence., Results: Eight participants had at least one positive antibody (5.4%, confidence intervals (CI) = 1.8-9), six had both (4.0% CI = 0.9-7.2) and two had only tTG positive. An intestinal biopsy was performed in four of these participants, finding a marked villous atrophy in three and partial atrophy in one., Conclusions: Five percent of this group of patients with CTD or IA had positive antibodies for CD.